Gossamer Bio is trading at $10.32, up 5.63%, alongside broader market gains; no direct catalyst is confirmed.
- No fresh company-specific announcement explaining the November 9 pre-market move surfaced in available news listings; the latest company investor-relations items shown were from September.
- Broader markets were mostly higher: the S&P 500 rose 0.69%, the Dow 1.08%, and the Nasdaq 0.48%.